glp-1 for crohn's Frontiers GLP1 Microdosing, Peptides & Random

Ive noticed that many patients experience improved blood sugar control, which is vital for preventing complications

Finally, the authors performed experiments on human subjects to evaluate the impact of LPS injection on plasma GLP-1 levels

In STEP-1 (Wilding et al., NEJM 2021), 68 weeks of once-weekly 2.4 mg semaglutide plus lifestyle intervention produced a mean body-weight reduction of about 15%, versus about 2.4% with placebo a large, clinically meaningful, well-replicated effect

The parallel is not exact, but it provides a plausible biological explanation for why some patients experience reduced sexual desire on GLP-1 therapy

A., Marinelli, C., Mannucci, E

Together, these studies will further define the cardiometabolic, renal, and rhythm-related benefits of GLP-1 RAs, potentially expanding their use beyond glycemic control